Aster DM Healthcare receives NCLT sanction order for Scheme of Amalgamation
The National Company Law Tribunal has issued and certified the amalgamation order, which has been formally received by Aster DM Healthcare Limited. This marks the transition from scheme approval to the filing and implementation phase. Under Section 230–232 of the Companies Act 2013, NCLT sanction is the critical approval gate; once certified, the scheme must be filed with the Registrar of Companies (ROC) before the merger becomes operational. The company has simultaneously intimated the NSE, signalling compliance with stock exchange continuous disclosure norms.
Why it mattersNCLT sanction concludes the judicial gate; the company must now comply with post-sanction filing obligations (CIR filing, stock exchange intimation protocol, and creditor/shareholder communication requirements under the Companies Act 2013) before operational merger becomes effective.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Corporate Filings Archive (PDF: Aster DM Healthcare - Intimation_CTC.pdf) · official
- Bar & Bench (Legal News Portal)
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026